欧洲重症监护病房创伤性脑损伤患者的质量指标:一项CENTER-TBI研究
本研究基于CENTER-TBI研究,纳入2014至2018年间54个ICU收治的2006例成人创伤性脑损伤患者,验证既往发表的共识性质量指标集。26/42项指标可从数据库中计算,多数指标可行性超过70%完整性。大多数质量指标依从性不理想,结构指标依从性26%至93%,过程指标20%至99%。7项过程指标和5项结局指标存在显著中心间变异(p<0.001),中位比值比1.51至4.14。结局指标统计不确定性普遍较高,7项中5项每中心事件数少于10。
要点
- 在54个欧洲ICU的2006例成人TBI患者中,42项质量指标仅26项可从CENTER-TBI数据库计算。
- 大多数质量指标依从性不理想:结构指标依从性26%至93%,过程指标依从性20%至99%。
- 7项过程指标和5项结局指标存在显著中心间变异(p<0.001),中位比值比1.51至4.14。
- 结局指标统计不确定性普遍较高,7项中5项每中心事件数少于10。
- 总体仅9项结构指标和5项过程指标显示有质量改进潜力,结局指标均无。
适用人群与场景
- 2014至2018年间入住54个欧洲ICU的2006例成人创伤性脑损伤患者,来自CENTER-TBI研究。
研究设计与关键结果
- 研究类型为基于CENTER-TBI研究的分析,纳入2006例成人患者、54个ICU,数据收集于2014至2018年。
- 42项质量指标中26项可从CENTER-TBI数据库计算。
- 多数质量指标可行性较高,完整性超过70%。
- 结构指标依从性26%至93%,过程指标依从性20%至99%,大多数质量指标依从性不理想。
- 7项过程指标和5项结局指标存在显著中心间变异(p<0.001),中位比值比范围1.51至4.14。
- 结局指标统计不确定性普遍较高,7项中5项每中心事件数少于10。
- 总体9项结构指标、5项过程指标显示有质量改进潜力,结局指标均无。
证据类型、等级与局限
- 证据类型为基于CENTER-TBI研究的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为未来研究应聚焦于实施工作和质量指标的持续再评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The aim of this study is to validate a previously published consensus-based quality indicator set for the management of patients with traumatic brain injury (TBI) at intensive care units (ICUs) in Europe and to study its potential for quality measurement and improvement.
METHODS: Our analysis was based on 2006 adult patients admitted to 54 ICUs between 2014 and 2018, enrolled in the CENTER-TBI study. Indicator scores were calculated as percentage adherence for structure and process indicators and as event rates or median scores for outcome indicators. Feasibility was quantified by the completeness of the variables. Discriminability was determined by the between-centre variation, estimated with a random effect regression model adjusted for case-mix severity and quantified by the median odds ratio (MOR). Statistical uncertainty of outcome indicators was determined by the median number of events per centre, using a cut-off of 10.
RESULTS: A total of 26/42 indicators could be calculated from the CENTER-TBI database. Most quality indicators proved feasible to obtain with more than 70% completeness. Sub-optimal adherence was found for most quality indicators, ranging from 26 to 93% and 20 to 99% for structure and process indicators. Significant (p < 0.001) between-centre variation was found in seven process and five outcome indicators with MORs ranging from 1.51 to 4.14. Statistical uncertainty of outcome indicators was generally high; five out of seven had less than 10 events per centre.
CONCLUSIONS: Overall, nine structures, five processes, but none of the outcome indicators showed potential for quality improvement purposes for TBI patients in the ICU. Future research should focus on implementation efforts and continuous reevaluation of quality indicators.
TRIAL REGISTRATION: The core study was registered with ClinicalTrials.gov, number NCT02210221, registered on August 06, 2014, with Resource Identification Portal (RRID: SCR_015582).
参考来源
- Huijben JA, Wiegers EJA, Ercole A, et al. Quality indicators for patients with traumatic brain injury in European intensive care units: a CENTER-TBI study. Crit Care. 2020. PMID: 32131882. doi:10.1186/s13054-020-2791-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。